Treviso, March 11, 2025 – SolidWorld Group S.p.A., listed on Euronext Growth Milan (ticker: S3D), is an Italian technology group, leader in the integration of advanced 3D digital solutions and artificial intelligence, for the industrial, biomedical and defense sectors, announces that Bio3DPrinting, a spin-off of the University of Pisa, has signed an agreement to launch a scientific collaboration with the University of Pavia, in partnership with Professor Michele Conti, Full Professor of Industrial Bioengineering and one of Italy’s leading experts in the field of bioprinting.
The agreement provides for the installation of a fully equipped Electrospider system and the establishment of a laboratory dedicated to 3D bioprinting technologies, with the aim of supporting scientific development activities, technological validation and knowledge dissemination within the sector.
Electrospider will be installed in a dedicated space within the department affiliated with Professor Conti. The laboratory will operate as a permanent demonstration centre for the technology, enhancing its visibility and facilitating access for researchers, companies and potential industrial partners, while also formalising the scientific collaboration with Bio3DPrinting.
The initiative has been developed with the support of Twin Helix, a non-exclusive distributor of the technology in Italy, which identified the University of Pavia as a centre of scientific excellence capable of fostering dialogue between academic research, industry and potential users of 3D bioprinting solutions. In return, the University of Pavia laboratory will serve as a permanent demonstration site for the technology, increasing its visibility and accessibility to researchers, companies and potential industrial partners, in addition to the formalisation of a scientific collaboration agreement with Bio3DPrinting.
The project, with an estimated duration of three years, envisages the joint development of research activities in the field of 3D bioprinting, establishing a continuous and direct relationship between Bio3DPrinting and the University of Pavia research group. The company will provide technical support throughout all project phases and will collaborate in the dissemination and valorisation of scientific results, including participation in publications and communication activities related to the research outcomes.
The value of the initiative is primarily strategic and scientific: the collaboration will enable the collection of qualified feedback on the technology, increase visibility within both academic and industrial environments, generate experimental evidence and establish a long-term relationship with a centre of research excellence.
A further relevant element of the collaboration is the involvement of Bio3DPrinting technology in the Bioprinting Winter School, organised annually by Professor Conti. The upcoming edition, scheduled, will include hands-on sessions using Electrospider, offering an important opportunity for engagement with researchers, universities and companies.
““The sharing of research and the continuous dialogue between industry and academia are key drivers of innovation in the bioprinting sector. Collaborating with leading institutions and research centres such as the University of Pavia means creating a virtuous ecosystem in which scientific expertise, technology and strategic vision converge to advance applied research and foster the transfer of results towards clinical and industrial applications. Our objective is to transform these advances into concrete opportunities capable of enabling increasingly standardised, personalised and innovative bioprinting approaches, benefiting those operating in research, industry and clinical practice ”. said Aurora De Acutis, co-fondatore di Bio3Dprinting.
Dr Michele Conti, Full Professor at the Faculty of Engineering of the University of Pavia, commented: “The collaboration with Bio3DPrinting represents an important opportunity to strengthen the dialogue between academic research and technological development in the field of biofabrication. The installation of Electrospider technology at LIVE Lab, within the Experimental Surgery Laboratory of the University of Pavia, will enable the exploration of new strategies for the design and manufacturing of biomimetic structures, while also supporting joint research activities, advanced training and knowledge transfer towards the industrial and biomedical sectors. We believe that the establishment of a permanent demonstration laboratory, integrated with other facilities already present within the DICAr department and supported by the CompMech group, can become a reference point for researchers, students and companies interested in emerging bioprinting technologies, further strengthening the University’s offering, including towards clinical institutions in the region ”.
To support the collaboration, Bio3DPrinting will provide full training on the use of the system at the time of installation and will ensure maintenance and technical support services throughout the duration of the agreement. This approach confirms the company’s positioning not only as a technology provider, but also as a strategic partner capable of supporting customers and research centres throughout the entire adoption and utilisation lifecycle of bioprinting solutions.
***
SolidWorld Group S.p.A. listed on Euronext Growth Milan (ticker: S3D), is an Italian technology group leader in the integration of advanced 3D digital solutions and artificial intelligence, serving strategic and next-generation industrial sectors. Founded in the early 2000s by engineer Roberto Rizzo, the Group drives the transformation of manufacturing companies toward “Factory 5.0” through proprietary software and hardware technologies that make production processes faster, more sustainable, and more efficient. Comprising 10 companies, 14 locations 3 tech hubs, and over 178 employees SolidWorld serves more than 10,000 clients. Key innovations include Electrospider, a 3D bioprinter capable of replicating human tissues and organs. As of December 31, 2024, the Group recorded a Value of Production equal to Eur 66,2 million and an EBITDA of Eur 6.5 million. www.solidworldgroup.it
CONTACTS
Investor Relations Manager
Elisabetta Cammarata
investor@solidworld.it
IR & Media Relations Advisor
Image Building Società Benefit
solidworld@imagebuilding.it – Tel. +39 02 89011300
